Recent News

By Category: Research

Bioterrorism Fear Led Scientists to Withhold Botulinum Toxin Info

(Nextgov) Researchers have uncovered a new breed of Botulinum toxin, however, they are withholding certain information about the neurotoxin out of concern it could be misused by individuals seeking to develop a biological weapon, National Public Radio reported on Wednesday. Botulinum toxin is produced by the bacterium, Clostridium botulinum, which is present in soil all Read More »

February 14, 2014
| Filed under North America, Agents & Toxins, Biosafety, Bioterrorism, and Research
Share

Early Tests Bode Well for Bioterrorism Treatment

(Nextgov) A potential drug for use against Marburg virus has been shown in initial testing to be safe for humans, the Boston Business Journal reported. Pharmaceutical firm Sarepta Therapeutics announced that when the treatment was given in various dosage amounts over two weeks to 40 volunteers in a Phase 1 study, the drug was discerned Read More »

February 14, 2014
| Filed under North America, Bioterrorism, Countermeasures, and Research
Share

Sarepta’s bioterrorism drug found safe in humans

(Boston Business Journal) While most attention on Sarepta Therapeutics has concerned its drugs for Duchenne’s muscular dystrophy, today the Cambridge biotech reported data from an early-stage trial of its potential drug for the bio-terrorism infection known as the Marburg virus. Marburg is a deadly infection disease first recognized in 1967 and endemic to Africa. Its Read More »

February 12, 2014
| Filed under North America, Bioterrorism, Countermeasures, and Research
Share

EPA Study on Bioterrorism Decontamination Techniques

(Global Biodefense) The U.S. Environmental Protection Agency (EPA), along with federal partners, this week announced the results of a multi-year project called Bio-Response Operational Testing and Evaluation (BOTE) that tested and evaluated decontamination techniques for a biological incident.